InvestorsHub Logo
Followers 16
Posts 1362
Boards Moderated 0
Alias Born 02/06/2014

Re: biopharm post# 252424

Sunday, 02/07/2016 4:13:56 PM

Sunday, February 07, 2016 4:13:56 PM

Post# of 346002
BIO Yes one of many future collaborations. Bayer partnered with Onxy for rights to Sorafenib to treat liver cancer in Asia so beta bodies should factor in due to its characteristics to possibly treat dense cancer in liver.

Bayer still has Peregrine on their list of collaborators.



Feb'12-Mar'13 ~8 times: CEO Steve King hints of future ex-US partner-driven Bavi+Sorafenib/LIVER trial in Asia:
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News